ADLM 2026 | Shanghai Sun Biotech: Showcasing a Comprehensive Coagulation Ecosystem on the Global Stage

From July 28 to 30, 2026, the 78th Annual Meeting of the American Association for Clinical Chemistry & Clinical Lab Expo (ADLM) kicked off in grand style at the Anaheim Convention Center, USA. Shanghai Sun Biotech, a frontrunner in China’s coagulation diagnostics sector, made a strong impression with its full-spectrum product ecosystem—covering instruments, reagents, consumables, and automated laboratory lines—signaling its unwavering commitment to expanding its global footprint.

Complete Product Portfolio Redefines Coagulation Excellence

At the expo, Shanghai Sun Biotech unveiled an end-to-end solution encompassing everything from routine screening to specialized testing. The UG Series coagulation analyzers emerged as a standout, integrating photometric and magnetic technologies with platelet aggregation functionality. Also drawing considerable interest were the UR Series high-throughput coagulation analyzers, designed for constant-speed efficiency, and the UL‑2000 LAS intelligent laboratory automation system. With a comprehensive test menu spanning routine coagulation, thrombophilia, fibrinolysis, and anticoagulant therapy monitoring, the company offers global laboratories a cost-effective, "one-stop" solution tailored to diverse clinical needs.

Accelerating Global Expansion: Making Chinese Solutions a Global Standard

This debut at ADLM represents far more than a product showcase—it marks a pivotal milestone in Shanghai Sun Biotech’s globalization journey. Since its founding in 2001, the company has dedicated over two decades to the field of thrombosis and hemostasis, establishing a business presence that now spans worldwide markets. Its compelling performance on this prestigious international stage underscores that homegrown Chinese coagulation diagnostic technologies have reached a level of quality capable of competing head-to-head with leading global brands.

Leveraging this premier platform, Shanghai Sun Biotech further strengthened its collaborative network with international distributors and healthcare institutions. The company reaffirmed its steadfast commitment to the philosophy of "Creating Products for Life," driving progress through innovation and striving to make Chinese-origin coagulation diagnostic solutions a trusted choice across the globe.